Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 224
Filter
1.
Br J Neurosurg ; 37(5): 1228-1232, 2023 Oct.
Article in English | MEDLINE | ID: mdl-33095069

ABSTRACT

Gliomas involving the cranial nerves III-XIII are rare. Even rarer are glioblastomas multiforme (GBMs) with only 10 cases previously reported. Oculomotor nerve involvement was described in only 2 patients. The mechanisms proposed so far include an origin from the nerve itself or an extension within the nerve of a midbrain tumor. We report the case of a 69-year-old man who presented with an isolated left oculomotor nerve palsy. He was found to have a left temporal GBM extended to the frontal lobe. Diagnostics and intraoperative and pathological findings clearly demonstrated a massive infiltration of the cisternal portion of the left oculomotor nerve. We suppose this could be the first case of direct oculomotor nerve invasion by exophytic spread of a supratentorial GBM or by subarachnoid seeding from a temporal tumor. Less probably, it could be the first case of an oculomotor nerve GBM with a temporal lobe invasion.


Subject(s)
Brain Stem Neoplasms , Glioblastoma , Glioma , Oculomotor Nerve Diseases , Male , Humans , Aged , Oculomotor Nerve/diagnostic imaging , Oculomotor Nerve/pathology , Glioblastoma/diagnosis , Glioblastoma/diagnostic imaging , Oculomotor Nerve Diseases/etiology , Oculomotor Nerve Diseases/surgery , Glioma/complications , Brain Stem Neoplasms/complications
2.
Brain Spine ; 2: 100909, 2022.
Article in English | MEDLINE | ID: mdl-36248151

ABSTRACT

•New insight into prognostic factors for recovery of clinical function following posterior decompression for degenerative cervical myelopathy.•An increase of IOM amplitude of at least 50% coupled with preoperative T2-only and diffuse T2 signal changes on MRI is a positive prognostic factors for clinical improvement 6 months after surgery.•Clinical improvement at 6 months follow-up can be expected in patients with T1 hypo intensity if a diffuse border of the lesion on T2 images is present.

3.
Psychoneuroendocrinology ; 93: 133-141, 2018 07.
Article in English | MEDLINE | ID: mdl-29727810

ABSTRACT

There is a need to identify new and more effective treatments for posttraumatic stress disorder (PTSD). Allopregnanolone and its stereoisomer pregnanolone (together termed ALLO) are metabolites of progesterone that positively and allosterically modulate GABA effects at GABAA receptors, thereby reducing anxiety and depression. Previous research revealed that women with PTSD had low cerebrospinal fluid (CSF) ALLO levels and a low ratio of ALLO to the allopregnanolone precursor 5α-DHP, consistent with deficient activity of the ALLO synthetic enzyme 3α-hydroxysteroid dehydrogenase (3α-HSD). The current study examined ALLO and the ratio of ALLO to 5α-DHP in plasma at rest and in response to psychophysiological stressors in trauma-exposed, medication-free women with and without PTSD. Participants were examined twice in random order during the early follicular phase (eFP) and mid-luteal phase (mLP) of the menstrual cycle. Plasma neurosteroids were measured using gas chromatography-mass spectrometry. Results indicate that the ALLO to 5α-DHP ratio in plasma increases between the eFP and mLP. In addition, women with PTSD have a lower ratio of ALLO to 5α-DHP than trauma-exposed healthy women, as well as blunted increases in this ratio in response to a moderately stressful laboratory procedure, i.e., differential fear conditioning, across the menstrual cycle. Clinically feasible testing for 3α-HSD dysfunction is critical to translating this line of research into clinical care. Measurement of this ratio in plasma could facilitate patient stratification in clinical treatment trials, as well as precision medicine targeting of treatments that address ALLO synthesis deficits in women with PTSD.


Subject(s)
Pregnanolone/metabolism , Progesterone/metabolism , Stress Disorders, Post-Traumatic/physiopathology , 5-alpha-Dihydroprogesterone/metabolism , Adult , Female , Follicular Phase , GABA Agents , Humans , Hydroxysteroid Dehydrogenases/metabolism , Luteal Phase , Menstrual Cycle , Neurotransmitter Agents/analysis , Neurotransmitter Agents/blood , Neurotransmitter Agents/metabolism , Pregnanolone/analysis , Pregnanolone/blood , Receptors, GABA/metabolism , Receptors, GABA-A/metabolism , Stress Disorders, Post-Traumatic/metabolism
4.
Allergy ; 73(6): 1151-1181, 2018 06.
Article in English | MEDLINE | ID: mdl-29105786

ABSTRACT

To address uncertainties in the prevention and management of influenza in people with asthma, we performed a scoping review of the published literature on influenza burden; current vaccine recommendations; vaccination coverage; immunogenicity, efficacy, effectiveness, and safety of influenza vaccines; and the benefits of antiviral drugs in people with asthma. We found significant variation in the reported rates of influenza detection in individuals with acute asthma exacerbations making it unclear to what degree influenza causes exacerbations of underlying asthma. The strongest evidence of an association was seen in studies of children. Countries in the European Union currently recommend influenza vaccination of adults with asthma; however, coverage varied between regions. Coverage was lower among children with asthma. Limited data suggest that good seroprotection and seroconversion can be achieved in both children and adults with asthma and that vaccination confers a degree of protection against influenza illness and asthma-related morbidity to children with asthma. There were insufficient data to determine efficacy in adults. Overall, influenza vaccines appeared to be safe for people with asthma. We identify knowledge gaps and make recommendations on future research needs in relation to influenza in patients with asthma.


Subject(s)
Asthma/complications , Asthma/epidemiology , Influenza, Human/complications , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Antiviral Agents/therapeutic use , Cost of Illness , Global Health , Humans , Immunogenicity, Vaccine , Influenza Vaccines/administration & dosage , Influenza Vaccines/adverse effects , Influenza Vaccines/immunology , Influenza, Human/therapy , Patient Outcome Assessment , Public Health Surveillance , Treatment Outcome , Vaccination
5.
Nutr Metab Cardiovasc Dis ; 27(3): 274-280, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27914696

ABSTRACT

BACKGROUND AND AIMS: Nutritional status (NS) is not routinely assessed in HF. We sought to evaluate whether NS may be additive to a comprehensive pre-discharge evaluation based on a clinical score that includes BMI (MAGGIC) and on an index of functional capacity (six minute walking test, 6mWT) in HF patients. METHODS AND RESULTS: The CONUT (Controlling Nutritional Status) score (including serum albumin level, total cholesterol and lymphocyte count) was computed in 466 consecutive patients (mean age 61 ± 11 years, NYHA class 2.6 ± 0.6, LVEF 34 ± 11%, BMI 27.2 ± 4.5) who had pre-discharge MAGGIC and 6MWT. The endpoint was all-cause mortality. Mild or moderate undernourishment was present in 54% of patients with no differences across BMI strata. The 12-month event rate was 7.7%. Deceased patients had a more compromised NS (CONUT 2.8 ± 1.5 vs 1.7 ± 1.3, p < 0.0001), and a more advanced HF (MAGGIC 28.2 ± 6.0 vs 22.0 ± 6.6, p < 0.0001; 6MWT 311.1 ± 102.2 vs. 408.9 ± 95.9 m, p < 0.0001). The 12-month mortality rate varied from 4% for well-nourished to 11% for undernourished patients (p = 0.008). At univariate analysis, the CONUT was predictive for all-cause mortality with a Hazard Ratio of 1.701 [95% CI 1.363-2.122], p < 0.0001. Multivariable analysis showed that the CONUT significantly added to the combination of MAGGIC and 6MWT and improved predictive discrimination and risk classification (c-index 0.82 [95% CI 0.75-0.88], integrated discrimination improvement 0.028 [95% CI 0.015-0.081]). CONCLUSIONS: In HF patients assessment of NS, significantly improves prediction of 12-month mortality on top of the information provided by clinical evaluation and functional capacity and should be incorporated in the overall assessment of HF patients.


Subject(s)
Decision Support Techniques , Heart Failure/diagnosis , Malnutrition/diagnosis , Nutrition Assessment , Nutritional Status , Aged , Biomarkers/blood , Body Mass Index , Databases, Factual , Exercise Tolerance , Female , Heart Failure/blood , Heart Failure/mortality , Heart Failure/physiopathology , Humans , Kaplan-Meier Estimate , Male , Malnutrition/blood , Malnutrition/mortality , Malnutrition/physiopathology , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Assessment , Risk Factors , Time Factors , Walk Test
6.
Ital J Pediatr ; 42(1): 87, 2016 Sep 22.
Article in English | MEDLINE | ID: mdl-27658827

ABSTRACT

BACKGROUND: Infants born at 34 to 36 weeks of gestation (late preterm) are at greater risk for adverse outcomes than those born at 37 weeks of gestation or later. Aim of this paper is to examine risk factors for late preterm births and to investigate the complications of the transition period in late preterm infants (LPIs). METHODS: All consecutive late preterm deliveries, excluded stillbirths, were included. Maternal and neonatal data, need for delivery room resuscitative procedures, temperature at birth (T1) and two hours after the admission (T2) were analyzed in all LPIs stratified by Gestational Age (GA) and divided into three groups (34, 35 and 36 weeks). RESULTS: Two hundred seventy-six LPIs were analyzed. Pregnancy complications were present in 72 mothers (26.1 %), more frequently at 34 weeks of gestation respect to 35 and 36 weeks (p = 0.008, p = 0.006 respectively). Forty seven LPIs (17.1 %) needed for any resuscitation and 37 (13.4 %) were ventilated at birth. LPIs at 34 weeks were significantly more likely to receive ventilation respect to those at 35 and 36. At T1 the mean temperature resulted lower at 34 weeks respect to 36 weeks (p = 0.03). At T2 respect to T1, the rate of normothermic neonates increased at 35 and 36 weeks (p = 0.003, p = 0.005, respectively). Hypoglicemia rate was similar among the groups; 66.7 % of hypoglicemic neonates were hypothermic at T1. The rate of respiratory diseases and NICU admission decreased with increasing GA. Higher number of neonates ventilated at birth developed respiratory disorders respect to those unventilated (40.5 % vs 8.4 %; p < 0.001). CONCLUSIONS: Transition period in LPIs may become critical, as resuscitation strategies can be required and heat loss can occur. LPIs, especially at 34 gestational weeks, are higher-risk group needing adequate and targeted management at birth.

7.
Pharmacol Res ; 113(Pt A): 108-115, 2016 11.
Article in English | MEDLINE | ID: mdl-27521837

ABSTRACT

Cannabinoids, endogenous and exogenously administered, are known to positively regulate food intake and energy balance. Since CB1 receptor antagonists reduce food intake and antagonize overweight, we developed a new CB1 receptor antagonist in an attempt to identify a compound with potential application in overeating disorders. The newly developed SM-11 compound dose-dependently decreases food intake in rats by 15-20%. Moreover, SM-11 reduces self-administration of palatable food in both food restricted and ad libitum fed rats, suggesting an action on the hedonic component of food intake. Thus, we next tested the effect of SM-11 on the stimulating properties of the CB1 receptor agonist WIN55,212-2 (WIN) on the electrophysiological activity of Nucleus Accumbens-projecting dopaminergic neurons of the ventral tegmental area (VTA). SM-11 fully and readily antagonized the WIN-induced increments in single spiking and burst firing of antidromically-identified dopamine neurons. When administered to naïve (no WIN-pretreated) rats, SM-11 did not alter basal neuronal activity, thereby suggesting a pure antagonistic profile. SM-11 thus appears as a promising candidate in the search of potential anti-obesity medications.


Subject(s)
Cannabinoid Receptor Antagonists/pharmacology , Dopamine/metabolism , Dopaminergic Neurons/drug effects , Eating/drug effects , Animals , Benzoxazines/pharmacology , Cannabinoids/pharmacology , Dopaminergic Neurons/metabolism , Male , Morpholines/pharmacology , Naphthalenes/pharmacology , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Cannabinoid, CB1/metabolism , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/metabolism
8.
Pathologica ; 108(1): 28-33, 2016 Mar.
Article in English | MEDLINE | ID: mdl-28195245

ABSTRACT

Signet-ring cell ependymoma is a rare variant of ependymoma with only seven cases described in literature. Biological behavior and prognosis of this entity are not well-known until now. We present a case of a 49-year-old female with a history of headache and gait instability. Magnetic resonance imaging showed an upper cervical tumor with cystic component and mural nodule. The patient underwent surgery. Microscopically some cells displayed an eccentric nucleus compressed to the periphery by vacuolated cytoplasm. Perivascular pseudorosettes and ependymal rosettes were seen only focally. The cells were positive for glial fibrillary acidic protein and epithelial membrane antigen. The diagnosis was ependymoma with diffuse signet-ring features, grade II according to the World Health Organization. It may be difficult to diagnose this unusual variant of ependymoma especially on small biopsies or frozen sections. A complete examination of the specimen is recommended with immunohistochemical confirmation to rule out potential morphologic mimics, such as metastatic adenocarcinomas and gliomas in the differential diagnosis.


Subject(s)
Brain Neoplasms/pathology , Carcinoma, Signet Ring Cell/pathology , Ependymoma/pathology , Biomarkers, Tumor/analysis , Biopsy , Brain Neoplasms/chemistry , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Carcinoma, Signet Ring Cell/chemistry , Carcinoma, Signet Ring Cell/diagnostic imaging , Carcinoma, Signet Ring Cell/surgery , Diagnosis, Differential , Ependymoma/chemistry , Ependymoma/diagnostic imaging , Ependymoma/surgery , Female , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Middle Aged , Predictive Value of Tests
9.
J Neurosurg Sci ; 59(4): 373-82, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26373668

ABSTRACT

Intraoperative neurophysiology (ION) is the gold standard to map and monitor brain functions during supratentorial surgery in critical areas. This is of great value for the surgery of brain gliomas in adults, but the same ION techniques can be used in the pediatric population with respect to both epilepsy and brain tumor surgery. While the principles of most ION techniques are the same for adults and children, the developing nervous system has peculiar characteristics in terms of anatomical and physiological maturation of afferent and efferent pathways within the brain and the spinal cord. Accordingly, some adjustments, particularly with regards to stimulation parameters, are needed in younger children. This paper will review current ION techniques to assist during the resection of brain tumors in children, focusing on the aspects peculiar to mapping and monitoring of sensori-motor functions in the pediatric population. On the other hand, awake surgery, of common use in adult patients when aiming to identify cortical and subcortical cognitive functions, is of very limited use in children and will not be discussed here.


Subject(s)
Brain Mapping/methods , Brain Neoplasms/surgery , Intraoperative Neurophysiological Monitoring/methods , Neurosurgical Procedures/methods , Child , Humans
10.
Oncogene ; 33(22): 2866-75, 2014 May 29.
Article in English | MEDLINE | ID: mdl-23812426

ABSTRACT

RNA-binding proteins of the IMP family (insulin-like growth factor 2 (IGF2) mRNA-binding proteins 1-3) are important post-transcriptional regulators of gene expression. Multiple studies have linked high expression of IMP proteins, and especially of IMP-3, to an unfavorable prognosis in numerous types of cancer. The specific importance of IMP-3 for cancer transformation remains poorly understood. We here show that all three IMPs can directly bind the mRNAs of cyclins D1, D3 and G1 (CCND1, D3 and G1) in vivo and in vitro, and yet only IMP-3 regulates the expression of these cyclins in a significant manner in six human cancer cell lines of different origins. In the absence of IMP-3, the levels of CCND1, D3 and G1 proteins fall dramatically, and the cells accumulate in the G1 phase of the cell cycle, leading to almost complete proliferation arrest. Our results show that, compared with IMP-1 and IMP-2, IMP-3 is enriched in the nucleus, where it binds the transcripts of CCND1, D3 and G1. The nuclear localization of IMP-3 depends on its protein partner HNRNPM and is indispensable for the post-transcriptional regulation of expression of the cyclins. Cytoplasmic retention of IMP-3 and HNRNPM in human cancer cells leads to significant drop in proliferation. In conclusion, a nuclear IMP-3-HNRNPM complex is important for the efficient synthesis of CCND1, D3 and G1 and for the proliferation of human cancer cells.


Subject(s)
Cyclin D1/genetics , Cyclin D3/genetics , Cyclin G1/genetics , Neoplasms/genetics , Neoplasms/metabolism , RNA Processing, Post-Transcriptional , RNA-Binding Proteins/metabolism , Cell Cycle/genetics , Cell Line, Tumor , Cell Nucleus/metabolism , Cell Proliferation , Gene Expression Regulation , Heterogeneous-Nuclear Ribonucleoprotein Group M/metabolism , Humans , Protein Binding , Protein Transport , RNA, Messenger/genetics , RNA, Messenger/metabolism
11.
Acta Otorhinolaryngol Ital ; 34(6): 427-33, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25762836

ABSTRACT

Patients affected by vestibular schwannomas typically report a number of symptoms and minor disabilities after surgery. Therefore, surgeons dealing with this pathology should also try to achieve a good QoL for patients who have undergone tumour removal. The aim of this study was to analyse QoL in subjects undergoing surgery for vestibular schwannomas and to try to establish a relationship with both the tumour size and post-surgical alterations (e.g. facial motor dysfunctions, difficulties in balance, persistence of headache and tinnitus). A retrospective analysis was performed on a consecutive series of 81 patients affected by vestibular schwannomas and treated by a combined microscopic-endoscopic approach. Three groups of patients were identified on the basis of tumour size. Group 1 (lesions < 25 mm) with 31 patients (38%); Group 2 (lesions > 26 mm and < 40 mm) with 39 patients (48%); Group 3 (lesions > 41 mm) with 11 patients (14%). Data obtained with the Short Form Questionnaire showed a statistically significant difference in QoL in those undergoing intervention compared with a control group of healthy subjects. The Glasgow Benefit Inventory Questionnaire showed that 25 (31%) patients felt better, 11 (14%) felt similarly, and 45 (55%) felt poorer health conditions in comparison to the pre-surgical period. Concerning the relationship between preservation of facial nerve function and QoL, using the Glasgow Health Status Inventory, it appeared that only 34% of subjects with good facial nerve function (RGS grade I-II) complained of worsening of QoL, while 45% of those with serious facial nerve injury (RGS grade IV-V) referred poorer QoL. Moreover, the possibility of recovery of facial nerve function during the months following surgery was clearly highlighted by our analysis. Our study confirmed the close relation between tumour size and post-surgical QoL, which is worse for patients affected by larger lesions.


Subject(s)
Endoscopy , Microsurgery , Neuroma, Acoustic/surgery , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Quality of Life , Retrospective Studies , Surveys and Questionnaires , Treatment Outcome
12.
Br J Cancer ; 108(11): 2304-11, 2013 Jun 11.
Article in English | MEDLINE | ID: mdl-23695020

ABSTRACT

BACKGROUND: Eukaryotic translation elongation factor 1A2 (eEF1A2) is a known proto-oncogene. We proposed that stimulation of the eEF1A2 expression in cancer tissues is caused by the loss of miRNA-mediated control. METHODS: Impact of miRNAs on eEF1A2 at the mRNA and protein levels was examined by qPCR and western blot, respectively. Dual-luciferase assay was applied to examine the influence of miRNAs on 3'-UTR of EEF1A2. To detect miRNA-binding sites, mutations into the 3'-UTR of EEF1A2 mRNA were introduced by the overlap extension PCR. RESULTS: miR-663 and miR-744 inhibited the expression of luciferase gene attached to the 3'-UTR of EEF1A2 up to 20% and 50%, respectively. In MCF7 cells, overexpression of miR-663 and miR-744 reduced the EEF1A2 mRNA level by 30% and 50%. Analogous effects were also observed at the eEF1A2 protein level. In resveratrol-treated MCF7 cells the upregulation of mir-663 and mir-744 was accompanied by downregulation of EEF1A2 mRNA. Both miRNAs were able to inhibit the proliferation of MCF7 cells. CONCLUSION: miR-663 and miR-744 mediate inhibition of the proto-oncogene eEF1A2 expression that results in retardation of the MCF7 cancer cells proliferation. Antitumour effect of resveratrol may include stimulation of the miR-663 and miR-744 expression.


Subject(s)
Breast Neoplasms/enzymology , Breast Neoplasms/therapy , MicroRNAs/administration & dosage , Peptide Elongation Factor 1/genetics , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Growth Processes/genetics , Cell Movement/genetics , Down-Regulation , Female , Humans , MCF-7 Cells , MicroRNAs/genetics , Peptide Elongation Factor 1/antagonists & inhibitors , Peptide Elongation Factor 1/biosynthesis , Proto-Oncogene Mas , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Resveratrol , Stilbenes/pharmacology , Transfection
13.
Clin Ter ; 164(1): e35-9, 2013.
Article in English | MEDLINE | ID: mdl-23455750

ABSTRACT

Thyroid Paragangliomas are exceptionally rare tumors and only 35 documented cases have been reported in the literature. We report an additional unusual male case of thyroid Paraganglioma associated to a chronic lymphocytic thyroiditis and a papillary microcarcinoma. A 45-year-old man presented with a solitary thyroid nodule. Physical examination revealed a smooth, well-circumscribed, firm, mobile, painless thyroid nodule in the right lobe measuring 3 cm. Ultrasound examination showed a 40 mm hypoechoic, non-homogeneous nodule with peri- and intra-nodular vascular flow. An ultrasound-guided fine needle aspiration biopsy was performed showing the presence of atypical cells (Thy 3). He underwent a total thyroidectomy associated to VI level lymphectomy. Histology showed a thyroid Paraganglioma associated to a chronic lymphocytic thyroiditis and a papillary microcarcinoma measuring 0.3 cm in the greatest dimension. Thyroid Paraganglioma is an elusive tumor. It is difficult to diagnose and should be included in the differential diagnosis of all neuroendocrine tumors of the thyroid, even those arising in men or behaving in a locally aggressive fashion.


Subject(s)
Carcinoma, Papillary/pathology , Neoplasms, Multiple Primary/pathology , Paraganglioma/pathology , Thyroid Neoplasms/pathology , Biopsy, Fine-Needle , Carcinoma, Papillary/complications , Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/surgery , Diagnosis, Differential , Hashimoto Disease/complications , Humans , Male , Middle Aged , Neoplasms, Multiple Primary/complications , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/surgery , Paraganglioma/complications , Paraganglioma/diagnostic imaging , Paraganglioma/surgery , Thyroid Neoplasms/complications , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/surgery , Thyroidectomy , Treatment Outcome , Ultrasonography, Interventional
14.
Neth Heart J ; 21(2): 61-3, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23184601

ABSTRACT

The arterial baroreflex is an important determinant of the neural regulation of the cardiovascular system. It has been recognised that baroreflex-mediated sympathoexcitation contributes to the development and progression of many cardiovascular disorders. Accordingly, the quantitative estimation of the arterial baroreceptor-heart rate reflex (baroreflex sensitivity, BRS), has been regarded as a synthetic index of neural regulation at the sinus atrial node. The evaluation of BRS has been shown to provide clinical and prognostic information in a variety of cardiovascular diseases, including myocardial infarction and heart failure that are reviewed in the present article.

16.
Acta Otorhinolaryngol Ital ; 31(4): 248-52, 2011 Aug.
Article in English | MEDLINE | ID: mdl-22058600

ABSTRACT

The endoscopic endonasal approach is emerging as a feasible alternative to the trans-oral route for the resection of the odontoid process, when the latter produces a compression of the brainstem and cervicomedullary junction. This type of approach has some advantages, such as excellent pre-vertebral exposure of the cranio-vertebral junction in patients with small oral cavities and the possibility to avoid the use of mouth retractors. A typical case of a 24-year-old male patient with a previous diagnosis of type I Arnold-Chiari Malformation, suffering from a posterior dislocation of the odontoid process causing severe anterior compression of the brainstem, is presented to stress the potential of this technique. Trans-nasal endoscopic removal of the odontoid process was performed and resolution of the ventral compression of the brainstem was achieved. This report demonstrates that in selected cases, an endoscopic endonasal approach should now be considered an excellent alternative to the traditional trans-oral approach.


Subject(s)
Arnold-Chiari Malformation/complications , Endoscopy/methods , Odontoid Process/abnormalities , Odontoid Process/surgery , Humans , Male , Nose , Young Adult
17.
Neuropharmacology ; 60(7-8): 1007-16, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21074545

ABSTRACT

It is becoming increasingly clear that a dysfunction of the GABAergic/glutamatergic network in telencephalic brain structures may be the pathogenetic mechanism underlying psychotic symptoms in schizophrenia (SZ) and bipolar (BP) disorder patients. Data obtained in Costa's laboratory (1996-2009) suggest that this dysfunction may be mediated primarily by a downregulation in the expression of GABAergic genes (e.g., glutamic acid decarboxylase67[GAD67] and reelin) associated with DNA methyltransferase (DNMT)-dependent hypermethylation of their promoters. A pharmacological strategy to reduce the hypermethylation of GABAergic promoters is to administer drugs, such as the histone deacetylase (HDAC) inhibitor valproate (VPA), that induce DNA-demethylation when administered at doses that facilitate chromatin remodeling. The benefits elicited by combining VPA with antipsychotics in the treatment of BP disorder suggest that an investigation of the epigenetic interaction of these drugs is warranted. Our studies in mice suggest that when associated with VPA, clinically relevant doses of clozapine elicit a synergistic potentiation of VPA-induced GABAergic promoter demethylation. Olanzapine and quetiapine (two clozapine congeners) also facilitate chromatin remodeling but at doses higher than used clinically, whereas haloperidol and risperidone are inactive. Hence, the synergistic potentiation of VPA's action on chromatin remodeling by clozapine appears to be a unique property of the dibenzepines and is independent of their action on catecholamine or serotonin receptors. By activating DNA-demethylation, the association of clozapine or its derivatives with VPA or other more potent and selective HDAC inhibitors may be considered a promising treatment strategy for normalizing GABAergic promoter hypermethylation and the GABAergic gene expression downregulation detected in the postmortem brain of SZ and BP disorder patients. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Epigenesis, Genetic/drug effects , Schizophrenia/drug therapy , gamma-Aminobutyric Acid/genetics , Animals , Antipsychotic Agents/metabolism , Antipsychotic Agents/pharmacology , Bipolar Disorder/genetics , Bipolar Disorder/metabolism , Excitatory Amino Acid Agents/metabolism , Excitatory Amino Acid Agents/pharmacology , Excitatory Amino Acid Agents/therapeutic use , Gene Expression/drug effects , Humans , Interneurons/drug effects , Interneurons/physiology , Mice , Molecular Targeted Therapy , Reelin Protein , Schizophrenia/genetics , Schizophrenia/metabolism , gamma-Aminobutyric Acid/metabolism
18.
Neuroradiol J ; 24(2): 271-2, 2011 May 15.
Article in English | MEDLINE | ID: mdl-24059619

ABSTRACT

Idiopathic intracranial hypertension (IIH) is characterized by an increased intracranial pressure in the absence of expansive lesions or cerebrospinal fluid (CSF) circulation obstructions. Its physiopathology is still not fully understood. The diagnosis is currently established on clinical grounds (Dandy criteria) along with an invasive measurement of CSF dynamic parameters through the infusion test. This study compares the invasive pressure measurements with the biomechanical CSF parameters derived from a phase-contrast MR protocol to evaluate the accuracy and reliability of the phase-contrast MR protocol.

19.
Physiol Meas ; 31(7): 1021-36, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20585147

ABSTRACT

A novel approach for the estimation of baroreflex sensitivity (BRS) is introduced based on time-frequency analysis of the transfer function (TF). The TF method (TF-BRS) is a well-established non-invasive technique which assumes stationarity. This condition is difficult to meet, especially in cardiac patients. In this study, the classical TF was replaced with a wavelet transfer function (WTF) and the classical coherence was replaced with wavelet transform coherence (WTC), adding the time domain as an additional degree of freedom with dynamic error estimation. Error analysis and comparison between WTF-BRS and TF-BRS were performed using simulated signals with known transfer function and added noise. Similar comparisons were performed for ECG and blood pressure signals, in the supine position, of 19 normal subjects, 44 patients with a history of previous myocardial infarction (MI) and 45 patients with chronic heart failure. This yielded an excellent linear association (R > 0.94, p < 0.001) for time-averaged WTF-BRS, validating the new method as consistent with a known method. The additional advantage of dynamic analysis of coherence and TF estimates was illustrated in two physiological examples of supine rest and change of posture showing the evolution of BRS synchronized with its error estimations and sympathovagal balance.


Subject(s)
Baroreflex/physiology , Blood Pressure Determination/instrumentation , Blood Pressure Determination/methods , Animals , Computer Simulation , Female , Humans , Linear Models , Male , Middle Aged , Rabbits , Supine Position/physiology , Time Factors
20.
Curr Med Chem ; 17(11): 1067-91, 2010.
Article in English | MEDLINE | ID: mdl-20156158

ABSTRACT

The therapeutic approach to AIDS is based on the combination of different drugs in the highly active antiretroviral therapy (HAART) regimen. These drugs have a wide variety of side effects, and some strains of HIV can develop resistance: for these reasons new anti-HIV drugs are needed. In the wide field of anti-HIV medicine this review covers different classes of drugs which inhibit viral entry: in particular the classification of main categories, their mode of action and some new candidates for AIDS therapy are contemplated. Also covered in this review are respiratory syncytial virus (RSV) fusion inhibitors.


Subject(s)
Anti-HIV Agents/chemistry , Antiviral Agents/chemistry , Respiratory Syncytial Virus Infections/drug therapy , Anti-HIV Agents/chemical synthesis , Anti-HIV Agents/pharmacology , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antiviral Agents/therapeutic use , Benzimidazoles/chemistry , Benzimidazoles/therapeutic use , HIV Fusion Inhibitors/chemical synthesis , HIV Fusion Inhibitors/chemistry , HIV Fusion Inhibitors/pharmacology , HIV Infections/drug therapy , Humans , Palivizumab , Peptides/chemistry , Peptides/therapeutic use , Phenols/chemistry , Phenols/therapeutic use , Sulfonamides/chemistry , Sulfonamides/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...